How is the Viracta Therapeutics Inc today?

The Viracta Therapeutics Inc today is trading in the down by 0.00% at 0.02.

What is Viracta Therapeutics Inc Annual Net Profit?

Viracta Therapeutics Inc Annual Net Profit fell 7.22% in the last year to $51.06 M. Its sector's average net profit growth for the last fiscal year was -11.26%.

What is Viracta Therapeutics Inc Price to Earning Ratio?

Viracta Therapeutics Inc Price to Earning Ratio is -0.02, which is negative.

What is Viracta Therapeutics Inc Stock Price?

Viracta Therapeutics Inc Stock Price fell 97.53% and underperformed its sector by 103.12% in the past year.

What is Viracta Therapeutics Inc Quarterly Net profit?

Viracta Therapeutics Inc Quarterly Net profit rose 16.25% YoY to $10.55 M. Its sector's average net profit growth YoY for the quarter was -207.11%.

What is Viracta Therapeutics Inc Debt to Equity Ratio?

Viracta Therapeutics Inc Debt to Equity Ratio of 1.99 is higher than 1. This implies that company assets are financed through debt.

What is Viracta Therapeutics Inc Return on Equity(ROE)?

Viracta Therapeutics Inc Return on Equity(ROE) for the last financial year was -149.04%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Viracta Therapeutics Inc Mutual Fund Holding?

Viracta Therapeutics Inc Mutual Fund Holding decreased by 1.66% in the last quarter to 2.55.

What is Viracta Therapeutics Inc Interest Coverage Ratio?

Viracta Therapeutics Inc Interest Coverage Ratio is -12.78, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Viracta Therapeutics Inc Institutional Holding?

Viracta Therapeutics Inc Institutional Holding decreased by 2.14% in the last quarter to 6.98.

Viracta Therapeutics Inc XNAS: VIRX

Viracta Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Viracta Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Viracta Therapeutics Inc
Rating: 0.43925
Author: Trendlyne DVM scores

about

Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therap...

0.02 0.00 (0.00%)

97.67% Fall from 52W High

2,634 XNAS Volume

XNAS 16 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

0.0 / 100

Technically Bearish

17.6 / 100

No estimates available

Viracta Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Viracta Therapeutics Inc FAQ

How is Viracta Therapeutics Inc today?

Viracta Therapeutics Inc today is trading in the red, and is down by 0.00% at 0.02.

How has Viracta Therapeutics Inc performed historically?

Viracta Therapeutics Inc is currently trading down 0.00% on an intraday basis. In the past week the stock fell 0.00%. stock has been down 0.00% in the past quarter and fell -97.53% in the past year. You can view this in the overview section.